Global API Leader Harman Finochem is a large Indian API manufacturer with 45+ APIs and a dominant position in Metformin production, serving 75+ countries. Sales opportunities include expanding CRAMS partnerships and international API supply agreements with mid to large pharma companies seeking diversified API portfolios.

Quality and Compliance Multiple high‑level certifications (EDQM, WHO‑GMP, USFDA, TGA Australia, HPB Canada, Japanese MHLW) and cGMP compliance under ICH Q7A position Harman Finochem as a reliable supplier for regulated markets. Target conversations can emphasize audits, batch records, and scalable GMP capabilities to win surrogate manufacturing or long‑term supply contracts.

Strong Metformin Capacity As one of the largest global producers of Metformin with two GMP sites and 350,000 liters capacity, there is an opportunity to offer Metformin API supply stability, alternative sourcing options, and co‑development of related intermediates or dosage forms for customers facing supply risk.

CRAMS and Partnerships Global partnerships and contract manufacturing capabilities present a pathway to win business from firms seeking world‑class API development, scale‑up, and transfer of technology. Highlight end‑to‑end support from R&D through tech transfer to manufacturing to attract CDMO collaborations.

Sustainability and Innovation Commitment to UN SDGs, R&D focus, and robust QC labs can be leveraged to pursue partnerships with sustainability‑driven clients and risk‑conscious buyers. Propose value propositions around responsible sourcing, environmental stewardship, and long‑term cost‑competitive manufacturing.